secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2026-09-09T23:15:15+00:00
Accession:  0001493152-26-042021
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed enters ATM sales agreement to sell up to $9.4M common stock
------------------------------------------------------------------

- Agreement with A.G.P./Alliance Global Partners allows at-the-market sales of common stock up to $9,400,000.
- Commission of 3.0% on gross sales; legal fee reimbursements up to $65,000 at execution, $7,500 quarterly, $12,500 per refresh.
- Proceeds to be used for working capital and general corporate purposes.
- Offering under existing shelf registration (File No. 333-283994) effective April 15, 2025; prospectus supplement filed Sept 9, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315226042021/0001493152-26-042021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315226042021/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer